S&P 500   3,383.25 (+1.49%)
DOW   27,952.84 (+0.96%)
QQQ   272.58 (+2.79%)
AAPL   452.83 (+3.50%)
MSFT   210.04 (+3.27%)
FB   261.42 (+2.07%)
GOOGL   1,509.58 (+1.96%)
AMZN   3,166.51 (+2.79%)
NVDA   456.92 (+5.28%)
CGC   17.40 (+2.65%)
BABA   255.54 (+2.87%)
TSLA   1,552.82 (+12.98%)
GE   6.63 (-1.49%)
MU   48.58 (+1.72%)
AMD   82.44 (+7.23%)
T   30.20 (-0.26%)
F   7.11 (-1.66%)
ACB   9.86 (-1.60%)
GILD   68.89 (+1.16%)
NFLX   480.44 (+2.89%)
DIS   131.35 (+0.66%)
BAC   26.62 (-1.11%)
BA   173.96 (-3.43%)
S&P 500   3,383.25 (+1.49%)
DOW   27,952.84 (+0.96%)
QQQ   272.58 (+2.79%)
AAPL   452.83 (+3.50%)
MSFT   210.04 (+3.27%)
FB   261.42 (+2.07%)
GOOGL   1,509.58 (+1.96%)
AMZN   3,166.51 (+2.79%)
NVDA   456.92 (+5.28%)
CGC   17.40 (+2.65%)
BABA   255.54 (+2.87%)
TSLA   1,552.82 (+12.98%)
GE   6.63 (-1.49%)
MU   48.58 (+1.72%)
AMD   82.44 (+7.23%)
T   30.20 (-0.26%)
F   7.11 (-1.66%)
ACB   9.86 (-1.60%)
GILD   68.89 (+1.16%)
NFLX   480.44 (+2.89%)
DIS   131.35 (+0.66%)
BAC   26.62 (-1.11%)
BA   173.96 (-3.43%)
S&P 500   3,383.25 (+1.49%)
DOW   27,952.84 (+0.96%)
QQQ   272.58 (+2.79%)
AAPL   452.83 (+3.50%)
MSFT   210.04 (+3.27%)
FB   261.42 (+2.07%)
GOOGL   1,509.58 (+1.96%)
AMZN   3,166.51 (+2.79%)
NVDA   456.92 (+5.28%)
CGC   17.40 (+2.65%)
BABA   255.54 (+2.87%)
TSLA   1,552.82 (+12.98%)
GE   6.63 (-1.49%)
MU   48.58 (+1.72%)
AMD   82.44 (+7.23%)
T   30.20 (-0.26%)
F   7.11 (-1.66%)
ACB   9.86 (-1.60%)
GILD   68.89 (+1.16%)
NFLX   480.44 (+2.89%)
DIS   131.35 (+0.66%)
BAC   26.62 (-1.11%)
BA   173.96 (-3.43%)
S&P 500   3,383.25 (+1.49%)
DOW   27,952.84 (+0.96%)
QQQ   272.58 (+2.79%)
AAPL   452.83 (+3.50%)
MSFT   210.04 (+3.27%)
FB   261.42 (+2.07%)
GOOGL   1,509.58 (+1.96%)
AMZN   3,166.51 (+2.79%)
NVDA   456.92 (+5.28%)
CGC   17.40 (+2.65%)
BABA   255.54 (+2.87%)
TSLA   1,552.82 (+12.98%)
GE   6.63 (-1.49%)
MU   48.58 (+1.72%)
AMD   82.44 (+7.23%)
T   30.20 (-0.26%)
F   7.11 (-1.66%)
ACB   9.86 (-1.60%)
GILD   68.89 (+1.16%)
NFLX   480.44 (+2.89%)
DIS   131.35 (+0.66%)
BAC   26.62 (-1.11%)
BA   173.96 (-3.43%)
Log in

NASDAQ:CANBCanbiola Stock Price, Forecast & News

$0.82
+0.07 (+9.33 %)
(As of 08/12/2020 02:26 PM ET)
Add
Compare
Today's Range
$0.63
Now: $0.82
$0.82
50-Day Range
$0.75
MA: $1.30
$1.98
52-Week Range
$0.25
Now: $0.82
$12.00
Volume36,858 shs
Average Volume17,349 shs
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
BetaN/A
Canbiola Inc. develops and sells cannabidiol (CBD) based products for pain, insomnia, epilepsy, anxiety, inflammation, and nausea in the United States. The company provides CBD products derived from hemp, including oils, creams, moisturizers, chews, vapes, isolate, gel caps, concentrates, and water through its Website, and doctors and other medical professionals. It also offers WRAPmail, a technology that combines custom marketing content with organization email to provide marketing platform for organizations and personal use; and Bullseye Productivity Suite, a cloud-based system that consolidates office productivity tools into one online experience. The company was formerly known as WRAPmail, Inc. and changed its name to Canbiola, Inc. in May 2017. Canbiola, Inc. was founded in 2005 and is based in Hicksville, New York.
Read More

Beat the Market (BTM) Rank

Analyst Opinion: 0.0Community Rank: 2.0Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

0.40 out of 5 stars


Industry, Sector and Symbol

Industry Drug Manufacturers - Specialty & Generic
Sub-IndustryN/A
SectorMedical
Current SymbolNASDAQ:CANB
CUSIPN/A
CIKN/A
Phone516-590-1846

Debt

Price-To-Earnings

Sales & Book Value

Annual SalesN/A

Profitability

Miscellaneous

Employees4
Next Earnings DateN/A
OptionableNot Optionable
$0.82
+0.07 (+9.33 %)
(As of 08/12/2020 02:26 PM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive CANB News and Ratings via Email

Sign-up to receive the latest news and ratings for CANB and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











Canbiola (NASDAQ:CANB) Frequently Asked Questions

How has Canbiola's stock been impacted by COVID-19 (Coronavirus)?

Canbiola's stock was trading at $1.05 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization (WHO). Since then, CANB stock has decreased by 21.9% and is now trading at $0.82.
View which stocks have been most impacted by Coronavirus
.

Has Canbiola been receiving favorable news coverage?

News stories about CANB stock have trended negative this week, according to InfoTrie Sentiment. InfoTrie scores the sentiment of media coverage by reviewing more than six thousand news and blog sources in real-time. The firm ranks coverage of publicly-traded companies on a scale of negative five to positive five, with scores nearest to five being the most favorable. Canbiola earned a media sentiment score of -2.2 on InfoTrie's scale. They also assigned news articles about the company a news buzz of 10.0 out of 10, meaning that recent media coverage is extremely likely to have an impact on the company's share price in the next few days.
View the latest news about Canbiola
.

Who are some of Canbiola's key competitors?

What other stocks do shareholders of Canbiola own?

Who are Canbiola's key executives?

Canbiola's management team includes the following people:
  • Mr. Marco Alfonsi, CEO & Chairman of Directors (Age 58)
  • Mr. Stanley L. Teeple, CFO, Sec. & Director (Age 67)
  • Mr. David J. Posel, Chief Operating Officer of Pure Leaf Oil (Age 40)
  • Mr. Andrew W. Holtmeyer, Exec. VP of Bus. Devel. (Age 57)
  • Dr. Johnny J. Mack, Interim COO, Director & Member of Corp. Advisory Board

What is Canbiola's stock symbol?

Canbiola trades on the NASDAQ under the ticker symbol "CANB."

How do I buy shares of Canbiola?

Shares of CANB can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Canbiola's stock price today?

One share of CANB stock can currently be purchased for approximately $0.82.

What is Canbiola's official website?

The official website for Canbiola is www.canbiola.com.

How can I contact Canbiola?

The company can be reached via phone at 516-590-1846.

This page was last updated on 8/12/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.